Suppr超能文献

慢性淋巴细胞白血病细胞可诱导CD4和CD8 T细胞的基因表达发生变化。

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.

作者信息

Görgün Güllü, Holderried Tobias A W, Zahrieh David, Neuberg Donna, Gribben John G

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

出版信息

J Clin Invest. 2005 Jul;115(7):1797-805. doi: 10.1172/JCI24176. Epub 2005 Jun 16.

Abstract

To examine the impact of tumors on the immune system, we compared global gene expression profiles of peripheral blood T cells from previously untreated patients with B cell chronic lymphocytic leukemia (CLL) with those from age-matched healthy donors. Although the cells analyzed were not part of the malignant clone, analysis revealed differentially expressed genes, mainly involved in cell differentiation in CD4 cells and defects in cytoskeleton formation, vesicle trafficking, and cytotoxicity in CD8 cells of the CLL patients. In coculture experiments using CLL cells and T cells from healthy allogeneic donors, similar defects developed in both CD4 and CD8 cells. These changes were induced only with direct contact and were not cytokine mediated. Identification of the specific pathways perturbed in the T cells of cancer-bearing patients will allow us to assess steps to repair these defects, which will likely be required to enhance antitumor immunity.

摘要

为了研究肿瘤对免疫系统的影响,我们比较了未经治疗的B细胞慢性淋巴细胞白血病(CLL)患者外周血T细胞与年龄匹配的健康供体的外周血T细胞的整体基因表达谱。尽管所分析的细胞不是恶性克隆的一部分,但分析发现了差异表达基因,主要涉及CD4细胞中的细胞分化以及CLL患者CD8细胞中细胞骨架形成、囊泡运输和细胞毒性方面的缺陷。在使用CLL细胞和来自健康异体供体的T细胞进行的共培养实验中,CD4和CD8细胞均出现了类似的缺陷。这些变化仅由直接接触诱导,而非细胞因子介导。确定荷癌患者T细胞中受到干扰的特定途径将使我们能够评估修复这些缺陷的步骤,而增强抗肿瘤免疫力可能需要这些步骤。

相似文献

1
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells.
J Clin Invest. 2005 Jul;115(7):1797-805. doi: 10.1172/JCI24176. Epub 2005 Jun 16.
9
Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Cytometry B Clin Cytom. 2003 Nov;56(1):23-9. doi: 10.1002/cyto.b.10052.

引用本文的文献

1
Thrombotic Thrombocytopenic Purpura Triggered by Chronic Lymphocytic Leukemia: A Case Report.
Case Rep Oncol. 2025 Jul 7;18(1):1021-1027. doi: 10.1159/000546300. eCollection 2025 Jan-Dec.
3
Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemia.
Front Cell Dev Biol. 2025 Apr 17;13:1577081. doi: 10.3389/fcell.2025.1577081. eCollection 2025.
7
Relapsed/refractory CLL: the role of allo-SCT, CAR-T, and T-cell engagers.
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):474-481. doi: 10.1182/hematology.2024000570.
9
Rewiring the T cell-suppressive cytokine landscape of the tumor microenvironment: a new frontier for precision anti-cancer therapy.
Front Immunol. 2024 Aug 30;15:1418527. doi: 10.3389/fimmu.2024.1418527. eCollection 2024.
10
T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells.
Blood Adv. 2024 Sep 10;8(17):4633-4646. doi: 10.1182/bloodadvances.2023011934.

本文引用的文献

1
Immune recognition of self in immunity against cancer.
J Clin Invest. 2004 Aug;114(4):468-71. doi: 10.1172/JCI22685.
2
NF-kappaB activation pathways induced by T cell costimulation.
FASEB J. 2003 Dec;17(15):2187-93. doi: 10.1096/fj.02-1100rev.
6
Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL).
Eur J Haematol. 2002 May;68(5):299-306. doi: 10.1034/j.1600-0609.2002.01612.x.
7
T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
Blood. 2002 Jul 1;100(1):167-73. doi: 10.1182/blood.v100.1.167.
8
The Nck family of adapter proteins: regulators of actin cytoskeleton.
Cell Signal. 2002 Sep;14(9):723-31. doi: 10.1016/s0898-6568(02)00027-x.
9
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6955-60. doi: 10.1073/pnas.102181599.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验